2006
DOI: 10.1159/000093276
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Inhibition of Nitric Oxide Production Aggravates Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty Rats

Abstract: Background: Nitric oxide (NO) is known to play a role in diabetic nephropathy, but the molecular basis for this effect remains unclear. Method: Otsuka Long-Evans Tokushima Fatty spontaneous diabetic rat models were used along with Long-Evans Tokushima Otuska rat models as age-matched controls. Either L-arginine (a NO precursor) or L-NAME (a nitric oxide synthase inhibitor) was administered from the age of 22 weeks. Clinical parameters and serum and urinary NO2+NO3 levels were measured, in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 42 publications
1
17
0
Order By: Relevance
“…This idea subsequently received experimental support in type 2 diabetes complicated by nephropathy (27). The overarching microvascular damage hypothesis is consistent with our current findings of loss of renal vascular barrier function, and those of others regarding defective renal nitric oxide synthesis (14), which presumably amplifies renal vasculopathy and resulting nephropathy (18).…”
Section: Discussionsupporting
confidence: 91%
“…This idea subsequently received experimental support in type 2 diabetes complicated by nephropathy (27). The overarching microvascular damage hypothesis is consistent with our current findings of loss of renal vascular barrier function, and those of others regarding defective renal nitric oxide synthesis (14), which presumably amplifies renal vasculopathy and resulting nephropathy (18).…”
Section: Discussionsupporting
confidence: 91%
“…82 In addition, full NOS3 deficiency sensitizes mice to type I 31 or type II DN. 83,84 Furthermore, the ÂĄ786C NOS3 gene variant is associated with a high urine albumin-to-creatinine ratio and a high risk of albuminuria in European American families. 85 The low expression of NOS3 in mice, comparable to that associated with human NOS3 variants, promotes diabetic nephropathy independent of its effects on blood pressure.…”
Section: Discussionmentioning
confidence: 99%
“…As NO may increase both blood flow and vascular permeability, it has been suggested as an important mediator responsible for the vascular changes that have been described in early diabetic nephropathy [28]. However, in several studies [29,30,31,32], inhibition of NO action and genetic variation of NO synthetase exacerbate, not attenuate, diabetic nephropathy. These findings suggest that increased production of NO in early diabetic nephropathy is compensative for blood pressure elevation or vascular endothelial damage.…”
Section: Discussionmentioning
confidence: 99%